The effect of lyophilised oral faecal microbial transplantation on functional outcomes in dogs with diabetes mellitus
Journal of Small Animal Practice · 2025
DOI: 10.1111/jsap.13865 ↗At a glance
Journal article in Journal of Small Animal Practice, 2025. Written by R Brown and 10 co-authors. Institution: Department of Veterinary Clinical Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA. Major MEDLINE topics: Fecal Microbiota Transplantation, Dog Diseases, Diabetes Mellitus. Cited 2 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY 4.0). Funded by: University of Illinois at Urbana-Champaign Companion Animal Research Grant Program.
Topics: Diabetes mellitus
Abstract (original language)
Objectives
We aimed to determine if oral faecal microbiota transplantation improves indices of glycaemic control, changes the faecal dysbiosis indices, alters faecal short‐chain fatty acid and bile acid profiles and increases serum glucagon‐like‐peptide 1 concentrations in diabetic dogs. Materials and Methods In this prospective randomised, placebo‐controlled, double‐blinded pilot study, we recruited nine diabetic dogs (five faecal microbiota transplantation and four placebo) and nine healthy controls.
Results
Compared to healthy dogs, diabetic dogs had altered faecal short‐chain fatty acid and bile acid profiles. In the first 30 days, the faecal microbiota transplantation group had a more rapid decline in interstitial glucose; however, the mean interstitial glucose of the faecal microbiota transplantation recipients did not differ from the placebo recipients at the end of the study. Compared with placebo, faecal microbiota transplantation recipients had a decreased 24‐hour water intake at day 60 and increased faecal abundance of Faecalibacterium . Clinical Significance This study provides a proof of concept for faecal microbiota transplantation in canine diabetes, and its data could inform the design of future large‐scale studies. Further investigation is required to determine whether faecal microbiota transplantation would have any role as an adjunctive therapy in canine diabetes and to elucidate the mechanisms by which faecal microbiota transplantation may provide a beneficial clinical effect in canine diabetes.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Veterinary Clinical Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
- Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, Texas A&M University, College Station, Texas, USA.
- AnimalBiome, Oakland, California, USA.
- School of Agriculture and Environment, Massey University, Palmerston North, New Zealand.
Funding
- University of Illinois at Urbana-Champaign Companion Animal Research Grant Program
Cite
APA
Brown, R., Barko, P., Ruiz Romero, J. D. J., Williams, D. A., Gochenauer, A., Nguyen-Edquilang, J., Suchodolski, J. S., Pilla, R., Ganz, H., Lopez-Villalobos, N., & Gal, A. (2025). The effect of lyophilised oral faecal microbial transplantation on functional outcomes in dogs with diabetes mellitus. Journal of Small Animal Practice. https://doi.org/10.1111/jsap.13865
Vancouver
Brown R, Barko P, Ruiz Romero JDJ, Williams DA, Gochenauer A, Nguyen-Edquilang J, et al. The effect of lyophilised oral faecal microbial transplantation on functional outcomes in dogs with diabetes mellitus. Journal of Small Animal Practice. 2025. doi:10.1111/jsap.13865
BibTeX
@article{Brown2025,
author = {Brown, R and Barko, P and Ruiz Romero, J D J and Williams, D A and Gochenauer, A and Nguyen-Edquilang, J and Suchodolski, J S and Pilla, R and Ganz, H and Lopez-Villalobos, N and Gal, A},
title = {The effect of lyophilised oral faecal microbial transplantation on functional outcomes in dogs with diabetes mellitus},
journal = {Journal of Small Animal Practice},
year = {2025},
doi = {10.1111/jsap.13865}
}
EUVIMED